Thursday, July 11, 2013

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening...

Background: Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis (RENEW http://t.co/sAzPIZzdDl

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/sAzPIZzdDl
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)